NCT03842436View on ClinicalTrials.gov

Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use

PHASE4CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

April 22, 2020

Study Completion Date

April 22, 2020

Conditions

HIV/AIDSSubstance Use DisordersAdherence, Medication

Interventions

DEVICE

Digital pill

Digital pills over encapsulating Truvada

DRUG

Truvada

Truvada prescribed with digital pills for PrEP

Trial Locations (1)

02215

Fenway Health, Boylston

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Gilead Sciences

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT03842436 - Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use | Biotech Hunter | Biotech Hunter